Haemophilia A News and Research

RSS
Hemophilia A is an X-linked, recessive, bleeding disorder caused by a deficiency in the activity of coagulation factor VIII. Affected individuals develop a variable phenotype of hemorrhage into joints and muscles, easy bruising, and prolonged bleeding from wounds. The disorder is caused by heterogeneous mutations in the factor VIII gene which maps to Xq28.
Baxter International, Inc. wins patent infringement case

Baxter International, Inc. wins patent infringement case

Improved method for genetically manipulating human embryonic stem cells

Improved method for genetically manipulating human embryonic stem cells

Guidelines for von Willebrand disease diagnosis and management

Guidelines for von Willebrand disease diagnosis and management

New guidelines for von Willebrand disease

New guidelines for von Willebrand disease

XYNTHA approved for teatment of hemophilia A by FDA

XYNTHA approved for teatment of hemophilia A by FDA

Transplanted cells can cure hemophilia

Transplanted cells can cure hemophilia

Baxter to develop recombinant Factor IX proteins to treat hemophilia B

Baxter to develop recombinant Factor IX proteins to treat hemophilia B

High-risk individuals less likely to follow through on HIV testing plans

High-risk individuals less likely to follow through on HIV testing plans

FDA approves change in storage conditions for Humate-P

FDA approves change in storage conditions for Humate-P

Irish Government launches program to provide life insurance to people with HIV, Hep C through contaminated blood products

Irish Government launches program to provide life insurance to people with HIV, Hep C through contaminated blood products

Judge acquits Canadian doctors, U.S. drug company in tainted blood case

Judge acquits Canadian doctors, U.S. drug company in tainted blood case

Prophylaxis effective at preventing joint bleeds and preserving joint function and structure in young boys with hemophilia A

Prophylaxis effective at preventing joint bleeds and preserving joint function and structure in young boys with hemophilia A

Xenomics issued European patent for Transrenal Nucleic Acid Technology for Prenatal Diagnostics

Xenomics issued European patent for Transrenal Nucleic Acid Technology for Prenatal Diagnostics

Baxter receives FDA approval for new dosage of Advate for hemophilia A

Baxter receives FDA approval for new dosage of Advate for hemophilia A

Baxter presents findings from the ADAPT study

Baxter presents findings from the ADAPT study

New platform for regulating the expression of therapeutic genes

New platform for regulating the expression of therapeutic genes

FDA approves Norditropin for short stature in children with Noonan syndrome

FDA approves Norditropin for short stature in children with Noonan syndrome

Study finds large number of new proteins implicated in Huntington's disease

Study finds large number of new proteins implicated in Huntington's disease

New treatments for brain hemorrhage

New treatments for brain hemorrhage

FDA approves new treatment for von Willebrand disease

FDA approves new treatment for von Willebrand disease